A Case of Long Partial Response to Combination Therapy of Bevacizumab and Capecitabine for Liver Metastases of Rectal Cancer

Publisher： Karger

E-ISSN： 1662-0631|5|1|28-32

ISSN： 1662-0631

Source： Case Reports in Gastroenterology, Vol.5, Iss.1, 2011-01, pp. : 28-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

By Gasparini Giampietro   Torino Francesco   Ueno Takayuki   Cascinu Stefano   Troiani Teresa   Ballestrero Alberto   Berardi Rossana   Shishido Junichi   Yoshizawa Akihiko   Mori Yukiko   Nagayama Satoshi   Morosini Paola   Toi Masakazu  

Angiogenesis, Vol. 15, Iss. 1, 2012-03 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

Response to Modified TEGAFIRI in a Patient with Synchronous Multiple Liver Metastases of Colon Cancer

By  

Case Reports in Gastroenterology, Vol. 5, Iss. 1, 2011-02 ,pp. : 95-99

Karger

Access to resources Recommend Favorite

Complete Response after Neoadjuvant Therapy in Rectal Cancer: To Operate or Not to Operate?

By  

Digestive Diseases, Vol. 30, Iss. 2, 2012-11 ,pp. : 109-117

Karger

Access to resources Recommend Favorite

Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative

By  

Digestion, Vol. 94, Iss. 3, 2016-10 ,pp. : 129-137

Karger

Access to resources Recommend Favorite

Neoadjuvant Short- or Long-Term Radio(chemo)therapy for Rectal Cancer: How and Who Should Be Treated?

By  

Digestive Diseases, Vol. 30, Iss. 2, 2012-11 ,pp. : 102-108

Karger

Access to resources Recommend Favorite